to Supply SARS-CoV-2 RT-PCR Test in Canadian Market BGI Genomics announced today that its subsidiary BGI Americas Corporation has received authorization under Interim Order from Health Canada to supply its Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2 in the Canadian market. The testing kit is part of an integrated solution that includes automated extraction methods...Continue Reading

to Enable COVID-19 Testing for 30% of the Population in the Next 8 Months SHENZHEN, China, April 27, 2020: BGI Genomics Co., Ltd. (SZSE:300676), and Saudi Arabia’s National Unified Procurement Company (NUPCO) have signed an agreement to establish Six “Huo-Yan” (“Fire Eye”) laboratories in Saudi Arabia to fight the COVID-19 pandemic. BGI will provide its...Continue Reading